Two Sigma Investments, LP Atara Biotherapeutics, Inc. Transaction History

Two Sigma Investments, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $29,712 - $224,780	129,184 New	129,184 $65,000
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $22,891 - $46,393	15,261 New	15,261 $24,000
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $230,268 - $418,523	80,796 Added 682.8%	92,629 $303,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $33,724 - $103,302	11,833 New	11,833 $45,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $3.62 Million - $4.9 Million	-246,136 Closed	0 $0

Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $2.85 Million - $4.25 Million	-237,314 Reduced 49.09%	246,136 $4.41 Million
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $6.09 Million - $7.83 Million	-472,259 Reduced 49.41%	483,450 $7.52 Million
Q1 2021 May 17, 2021	SELL	$14.0 - $20.72 $557,032 - $824,407	-39,788 Reduced 4.0%	955,709 $13.7 Million
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $5.87 Million - $12.2 Million	463,626 Added 87.17%	995,497 $19.5 Million
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $4.93 Million - $6.56 Million	413,217 Added 348.25%	531,871 $6.89 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $283,512 - $562,129	37,651 Added 46.48%	118,654 $1.73 Million
Q1 2020 May 15, 2020	SELL	$5.69 - $17.78 $908,283 - $2.84 Million	-159,628 Reduced 66.34%	81,003 $689,000
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $1.61 Million - $2.48 Million	147,799 Added 159.21%	240,631 $3.96 Million
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $1.12 Million - $1.85 Million	92,832 New	92,832 $1.31 Million

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.